4//SEC Filing
Price P Schaefer 4
Accession 0001192482-11-000264
CIK 0001301081other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 4:15 PM ET
Size
9.7 KB
Accession
0001192482-11-000264
Insider Transaction Report
Form 4
Pharmasset IncVRUS
Price P Schaefer
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2011-09-01−40,000→ 411,914.66 totalExercise: $1.50Exp: 2014-08-10→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock, $.001 par value per share
2011-09-01$1.50/sh+40,000$60,000→ 806,566 total - Sale
Common Stock, $.001 par value per share
2011-09-01$65.63/sh−40,000$2,625,032→ 766,566 total
Footnotes (6)
- [F1]This transaction is the result of standing instructions set forth in a Rule 10b5-1 plan previously established by the filer.
- [F2]The number of shares beneficially owned reflected in Items 5 and 9 of this Form 4 represent a two-for-one stock split of the Issuer's common stock which is structured in the form of a dividend payable on August 31, 2011 to the stockholders of record at the close of business on August 22, 2011.
- [F3]Represents the weighted average sales price for price increments ranging from $64.52 to $66.77.
- [F4]The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- [F5]The options were granted on August 10, 2004. 25% were vested on the one-year anniversary of the grant and 6.25% became vested quarterly thereafter.
- [F6]Following this transaction, Mr. Price has 1,286,597.34 options remaining in total from all grants, including the 411,914.66 options reported above.
Documents
Issuer
Pharmasset Inc
CIK 0001301081
Entity typeother
Related Parties
1- filerCIK 0001397332
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 4:15 PM ET
- Size
- 9.7 KB